Trump’s 200% tariff threat could send shockwaves through pharma supply chains
US President Donald Trump's 200% tariff threat on the pharmaceutical industry is a "shock" that will reverberate through global supply…
US President Donald Trump's 200% tariff threat on the pharmaceutical industry is a "shock" that will reverberate through global supply…
US-based PanTher Therapeutics has initiated a trial of its chemotherapy-eluting patch, which it hopes will make cancer therapy more tolerable. The…
Experts are emphasising that safeguarding patient data from corporations and cyberattacks is vital for the NHS to create a single…
European residents must be fully informed to properly trust the incoming European Health Data Space (EHDS) regulation if it is…
BioOrbit aims to kick off pre-clinical trials to study protein crystals for monoclonal antibodies (mAbs) produced in a pharmaceutical factory…
With the 10-year Health Plan on the horizon, the NHS could learn some tricks from France, Germany and the Nordics.…
Novo Nordisk is looking to partner with digital companies at every stage of the weight loss journey to help patients…
Oxford-based company Genomics is launching its Health Insights test across the UK, which will be used to predict and prevent…
European companies must be able to provide developed and scalable business models if they want to enter the US to…
A £29bn investment into the National Health System (NHS) is ‘substantial’, but reform of the system is essential to ‘fix…